Collegium Pharmaceutical, Inc Liquidation Value

COLL Other

Cash & Equivalents

$231.25M
As of 2025-12-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $231.25M
Total Obligations: -$445.57M
$-214.31M
Per share: $-6.76
Period: 2025-12-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $231.25M
AR: $211.33M
Total Obligations: -$445.57M
$-2.99M
Per share: $-0.09
Period: 2025-12-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $231.25M
AR: $211.33M
Inventory: $40.91M
Total Obligations: -$445.57M
$37.92M
Per share: $1.20
Period: 2025-12-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$-214.31M$-6.76
Liquid Liquidation Value$-2.99M$-0.09
Operating Liquidation Value$37.92M$1.20

Key Components (as of 2025-12-31)

Cash & Equivalents$231.25M
Accounts Receivable$211.33M
Inventory$40.91M
Current Liabilities$440.03M
Long-term DebtN/A
Op. Lease Liability$5.54M
Finance LeaseN/A
Shares Outstanding31.7M

Explore all 213 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2025-12-31$231.25M$211.33M$40.91M$10.66M$440.03MN/A$5.54MN/A
2025-09-30$150.10M$233.95M$38.05M$7.65M$452.93MN/A$5.87MN/A
2025-06-30$117.35M$213.02M$38.15M$10.89M$464.61MN/A$6.19MN/A
2025-03-31$96.19M$228.71M$37.22M$17.85M$486.71MN/A$6.50MN/A
2024-12-31$70.56M$228.54M$35.56M$3.93M$509.51MN/A$6.81MN/A
2024-09-30$38.96M$228.46M$38.03M$3.14M$459.43MN/A$7.18MN/A
2024-09-03$25.00MN/AN/AN/AN/AN/AN/AN/A
2024-06-30$172.89M$183.85M$27.86M$2.41M$461.72MN/A$6.63MN/A

Comments

SEC Filings

PeriodFormFiledLink
2025-12-31 10-K 2026-02-26 View
2025-09-30 10-Q 2025-11-06 View
2025-06-30 10-Q 2025-08-07 View
2025-03-31 10-Q 2025-05-08 View
2024-12-31 10-K 2025-02-27 View
2024-09-30 10-Q 2024-11-07 View
2024-06-30 10-Q 2024-08-08 View
2024-03-31 10-Q 2024-05-09 View

Community Notes

Loading notes...

Questions

Loading questions...